Edition:
United States

Calithera Biosciences Inc (CALA.OQ)

CALA.OQ on NASDAQ Stock Exchange Global Select Market

8.50USD
11:58am EST
Change (% chg)

$0.05 (+0.59%)
Prev Close
$8.45
Open
$8.45
Day's High
$8.60
Day's Low
$8.32
Volume
90,847
Avg. Vol
132,030
52-wk High
$20.00
52-wk Low
$3.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 7.25 -0.171
Jun '17 7.26 -0.147
Mar '17 4.19 -0.221
FY 2016 Dec '16 0.00 -0.452
Sep '16 0.00 -0.438
Jun '16 0.00 -0.546
Mar '16 0.00 -0.521
FY 2015 Dec '15 0.00 -0.444
Sep '15 0.00 -0.492
Jun '15 0.00 -0.435
Mar '15 0.00 -0.438
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 5.46 7.30 0.00 0.00
Quarter Ending Mar-18 1 6.90 6.90 6.90 --
Year Ending Dec-17 4 24.24 26.00 19.00 0.00
Year Ending Dec-18 4 24.52 28.27 16.80 27.90
Earnings (per share)
Quarter Ending Dec-17 5 -0.22 -0.18 -0.29 -0.36
Quarter Ending Mar-18 2 -0.16 -0.11 -0.21 --
Year Ending Dec-17 5 -0.75 -0.68 -0.83 -1.54
Year Ending Dec-18 5 -1.08 -0.45 -2.34 -1.52
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 196.13 36.03
P/E High - Last 5 Yrs. -- 279.92 45.26
P/E Low - Last 5 Yrs. -- 93.48 24.26
Beta -- 0.82 0.91
Price to Sales (TTM) 16.03 117.54 5.90
Price to Book (MRQ) 1.90 23.08 5.74
Price to Tangible Book (MRQ) 1.90 26.92 7.33
Price to Cash Flow (TTM) -- 106.51 24.72
% Owned Institutions 92.61 5.59 1.38

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.02 5.23
Payout Ratio(TTM) -- 98.85 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -4.33 6.77
Sales (TTM) vs TTM 1 Yr. Ago -- 30.49 5.56
Sales - 5 Yr. Growth Rate -- 33.28 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago 60.93 -148.85 7.88
EPS (TTM) vs TTM 1 Yr. Ago 49.14 -- --
EPS - 5 Yr. Growth Rate -- 44.44 10.92
Capital Spending - 5 Yr. Growth Rate -- 41.25 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.55
Current Ratio (MRQ) 4.60 5.63 3.57
LT Debt to Equity (MRQ) 0.00 16.33 13.26
Total Debt to Equity (MRQ) 0.00 18.85 19.22
Interest Coverage (TTM) -- -144.78 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.82 54.87
Gross Margin - 5 Yr. Avg. -- 55.59 52.44
EBITD Margin (TTM) -146.62 -- --
EBITD - 5 Yr. Avg -- -215.54 15.70
Operating Margin (TTM) -148.38 -635.70 6.77
Operating Margin - 5 Yr. Avg. -- -232.57 11.08
Pre-Tax Margin (TTM) -141.02 -605.50 7.60
Pre-Tax Margin - 5 Yr. Avg. -- -232.71 11.49
Net Profit Margin (TTM) -141.02 -603.22 3.83
Net Profit Margin - 5 Yr. Avg. -- -236.06 7.78
Effective Tax Rate (TTM) -- 15.54 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.17 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 374,020 22,216,302 857,902,259
Net Income/Employee (TTM) -527,440 -2,116,531 100,310,105
Receivable Turnover (TTM) -- 26.19 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.14 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -19.94 -9.39 11.35
Return on Assets - 5 Yr. Avg. -- 0.13 12.32
Return on Investment (TTM) -23.73 -11.69 14.48
Return on Investment - 5 Yr. Avg. -- 3.37 16.13
Return on Equity (TTM) -24.89 -36.44 16.06
Return on Equity - 5 Yr. Avg. -- 5.73 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -7.81 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Calithera Biosciences Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -13.78 -15.93 17 96
13 Week -44.22 -47.51 8 74
26 Week -40.28 -45.23 17 59
52 Week 164.06 124.36 94 62
YTD 160.00 119.49 92 52
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 92.48%
# of Holders: 137
Total Shares Held: 32,808,727
3 Mo. Net Change: 152,930
# New Positions: 25
# Closed Positions: 20
# Increased Positions: 69
# Reduced Positions: 56
# Net Buyers: 13
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.